Co-delivery of paclitaxel and anti-VEGF siRNA by tripeptide lipid nanoparticle to enhance the anti-tumor activity for lung cancer therapy

The combination of chemotherapeutic drug paclitaxel (PTX) and VEGF siRNA could inhibit cancer development with synergistic efficacy. However, efficient and safe delivery systems with high encapsulation efficiency of PTX and a long-time release of drugs are urgently needed. In this study, novel nanop...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Drug Deliv
Autori principali: Zhang, Chuanmin, Zhao, Yinan, Zhang, Enxia, Jiang, Meilin, Zhi, Defu, Chen, Huiying, Cui, Shaohui, Zhen, Yuhong, Cui, Jingnan, Zhang, Shubiao
Natura: Artigo
Lingua:Inglês
Pubblicazione: Taylor & Francis 2020
Soggetti:
Research Article
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC7594708/
https://ncbi.nlm.nih.gov/pubmed/33096948
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/10717544.2020.1827085
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi